HBOT & Wellness & Longevity — What the Research Shows · Oceanside, CA
WELLNESS ISN'T
THE ABSENCE OF
DISEASE.
Longevity researchers are discovering that how long and how well you live is determined largely by what happens at the cellular level — stem cell activity, mitochondrial function, inflammatory burden, and telomere health. Hyperbaric oxygen therapy is now being studied as a tool that may address several of these biological drivers simultaneously. This page explores what the science currently shows.
This page is educational and informational. It does not claim that HBOT treats, cures, or prevents any medical condition. HBOT is not an FDA-approved wellness or longevity treatment. Please work with a qualified healthcare provider for personalized health guidance.
What the Research Shows
800%
Increase in circulating stem cells over a course of HBOT — University of Pennsylvania1
37%
Reduction in senescent "zombie" cells — a primary driver of biological aging2
#1
Rated PT Clinic — North County 2025
The Biology of Longevity
HOW LONG YOU LIVE IS DECIDED AT THE CELLULAR LEVEL.
Longevity science has shifted dramatically in the past decade. What was once a vague concept — "living healthy" — is now being studied at the level of specific, measurable cellular processes that predict biological age far more accurately than chronological age.
The primary drivers researchers have identified are: telomere length (the protective caps on DNA that shorten with each cell division), senescent cell accumulation (dysfunctional "zombie" cells that drive chronic inflammation), stem cell activity (the body's repair and regeneration capacity), and mitochondrial function (cellular energy production efficiency).
The Four Cellular Drivers of Biological Age
Telomere length — shorter telomeres are associated with accelerated aging and disease risk
Senescent cells — "zombie" cells that accumulate with age and drive chronic inflammation
Stem cell reserve — the body's capacity to repair and regenerate tissue declines with age
Mitochondrial efficiency — energy production declines as mitochondria accumulate damage
"HBOT induced a 38% increase in telomere length and a 37% reduction in senescent cells — changes representing a significant reversal of cellular aging markers."
— Hachmo et al., Aging, 2020 (Tel Aviv University)
What Makes HBOT Interesting to Longevity Researchers
HBOT MAY ADDRESS MULTIPLE AGING DRIVERS SIMULTANEOUSLY.
Most longevity interventions address one mechanism at a time. What makes HBOT unusual — and what has attracted significant research interest — is that a single protocol appears to influence several of these aging drivers in parallel.
The 2020 Tel Aviv University trial documented simultaneous increases in telomere length and reductions in senescent cells following HBOT — two of the most significant cellular aging markers — in the same study population. The same research group has documented stem cell mobilization and mitochondrial effects in related work.
What the 2020 Trial Found
38% increase in telomere length — the largest documented increase from any non-pharmacological intervention
37% reduction in senescent T-cells — directly reducing the inflammatory burden that accelerates aging
Effects in healthy adults — not just in disease populations, suggesting broader wellness applicability
60-session protocol — five sessions per week over twelve weeks in a controlled research setting
Researchers are now working to determine how durable these effects are over time, whether repeat protocols maintain them, and which patient profiles respond most consistently.
WANT TO KNOW IF HBOT IS RIGHT FOR YOU?
The Research Angle
WHAT HBOT DOES
THAT RESEARCHERS
ARE INVESTIGATING
Hyperbaric oxygen therapy delivers 100% oxygen at increased atmospheric pressure — creating conditions researchers believe may influence the fundamental biology of aging and long-term health. Here are six mechanisms currently under investigation.
Telomere Lengthening
The 2020 Hachmo trial documented a 38% increase in telomere length following HBOT — the largest increase from any non-pharmacological intervention on record. Telomeres are the protective caps on chromosomes that shorten with each cell division; their length is one of the most reliable markers of biological age. Researchers are investigating how durable this effect is and what protocols produce it most consistently.
💥
Senescent Cell Clearance
The same trial found a 37% reduction in senescent immune cells — cells that accumulate with age, stop functioning normally, and secrete chronic inflammatory signals that drive biological aging. This senolytic effect was previously achievable only with experimental drugs. The finding has significant implications for longevity research, which increasingly views senescent cell burden as a primary target for intervention.
🔬
Stem Cell Mobilization
Research at the University of Pennsylvania found HBOT increased circulating stem cells by 800%. Stem cell activity is the body's primary repair and regeneration mechanism — and stem cell reserve declines with age, directly reducing the body's capacity to maintain tissue quality. By dramatically boosting circulating stem cells, HBOT may help compensate for this age-related decline in repair capacity.
Mitochondrial Function
Mitochondrial dysfunction is one of the hallmarks of cellular aging — damaged mitochondria produce less energy and more reactive oxygen species, creating a cycle that accelerates cellular decline. HBOT's oxygen surge supports mitochondrial function and stimulates mitochondrial biogenesis (production of new mitochondria). Researchers are investigating whether this effect contributes meaningfully to the reversal of aging markers observed in HBOT trials.
🔥
Systemic Inflammation Reduction
Chronic low-grade inflammation — sometimes called "inflammaging" — is one of the most consistent predictors of accelerated biological aging and age-related disease. HBOT has documented anti-inflammatory effects including reductions in pro-inflammatory cytokines and the senescent cell burden that drives them. Reducing systemic inflammation is among the most actionable targets in longevity research, and HBOT's effects here are increasingly well-documented.
🫚
Tissue Oxygenation and Repair
Tissue quality declines with age partly because repair processes slow and oxygen delivery to aging tissue decreases. HBOT delivers oxygen at concentrations far exceeding normal breathing, reaching tissue that circulation may not be adequately supplying. By restoring high-level oxygen availability, HBOT may support the ongoing repair and maintenance processes that keep tissue functioning at a younger biological level.
Important Context
Longevity research is one of the most exciting and fastest-moving areas in medicine — and HBOT's role within it is still being established. The 2020 cellular aging trial is a significant finding, but it was conducted in healthy older adults under a specific 60-session protocol in a research setting. Individual responses vary. HBOT is not approved as a longevity or anti-aging treatment. The most responsible framing is: promising research worth following, in a field that is actively developing.
The Clinical Evidence
WHAT THE STUDIES
HAVE FOUND
Three of the most significant findings in HBOT and longevity research — covering cellular aging markers, stem cell mobilization, and systemic repair capacity.
Human Trial · Aging 2020
38% TELOMERE LENGTHENING AND 37% SENESCENT CELL REDUCTION IN HEALTHY ADULTS
The landmark Tel Aviv University trial published in Aging (2020) enrolled healthy adults aged 64+ in a 60-session HBOT protocol. Researchers measured telomere length and senescent immune cell counts before and after — two of the most clinically relevant markers of biological age.
Results showed a 38% increase in telomere length and a 37% reduction in senescent T-cells — findings the authors described as a significant reversal of cellular aging markers. The telomere finding in particular drew widespread attention: a 38% increase from a non-pharmacological intervention had not previously been documented. Researchers noted the effects were measured in healthy adults, not disease populations, suggesting applicability to general wellness.
Source: Hachmo et al., Aging, 2020. DOI: 10.18632/aging.202188
Mechanistic Research · American Journal of Physiology 2006
800% STEM CELL INCREASE — THE BODY'S PRIMARY REPAIR AND REGENERATION SYSTEM
Dr. Stephen Thom's research at the University of Pennsylvania documented an 800% increase in circulating CD34+ stem cells following HBOT — the safest known method of stem cell mobilization. Stem cells are the body's primary repair and regeneration mechanism, and stem cell reserve declines significantly with age.
From a longevity standpoint, this is significant: maintaining robust stem cell activity is directly linked to tissue quality and repair capacity over time. By dramatically increasing circulating stem cells, HBOT may help compensate for the age-related decline in the body's endogenous repair system — supporting tissue maintenance in ways that slow biological deterioration.
Source: Thom et al., American Journal of Physiology, 2006. DOI: 10.1152/ajpheart.00306.2006
Long COVID RCT · Scientific Reports 2025
IMPROVEMENTS PERSISTED MORE THAN ONE YEAR POST-HBOT IN 232-PATIENT REGISTRY
A 232-patient registry study published in Scientific Reports (2025) examined long-term outcomes in patients who completed an HBOT protocol. The study measured quality of life, cognitive function, fatigue, and other wellness markers at follow-up more than one year after treatment ended.
Results showed that improvements persisted more than one year post-treatment — a finding with direct relevance to wellness applications. If HBOT's effects on cellular biology produce durable changes rather than temporary symptom relief, the wellness implications shift from "ongoing treatment" to "protocol with lasting effects." Researchers are working to characterize the durability of specific cellular markers in follow-up studies.
Source: Hadanny et al., Scientific Reports, 2025.
The Broader Research Context
Longevity medicine is one of the fastest-growing areas of health research, and HBOT sits at an interesting intersection: it is a clinically established technology with decades of safety data that is now being studied for mechanisms (telomere dynamics, senescent cell biology) that only recently became measurable. The 2020 Aging trial is widely cited in longevity circles and has prompted significant follow-up research at institutions worldwide.
At Land and Sea PT, we offer HBOT as a wellness service for people who take their long-term health seriously. Many of our HBOT patients are not dealing with an acute injury or illness — they're investing in their cellular health the same way they invest in sleep, nutrition, and exercise. If that resonates with you, we're glad to walk you through what a protocol might look like.
WANT TO KNOW IF HBOT IS RIGHT FOR YOU?
Invest in Your Cellular Health
LET'S HAVE A
CONVERSATION.
If you're serious about your long-term health and want to understand what HBOT is, what the research shows, and whether it fits into how you're approaching wellness — we're here for that conversation.
This page is educational only. HBOT is not an approved treatment for aging, longevity, or any related condition. Results vary between individuals. Please work with your healthcare provider for personalized guidance. HBOT at Land and Sea PT is offered as a wellness service.
📍 821 S Tremont St, Oceanside, CA
Serving Carlsbad · Vista · San Marcos · North County San Diego
References
  • Thom et al. "Stem cell mobilization by hyperbaric oxygen." American Journal of Physiology, 2006. DOI: 10.1152/ajpheart.00306.2006
  • Hachmo et al. "Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence." Aging, 2020. DOI: 10.18632/aging.202188
  • Hadanny et al. Scientific Reports, 2025.